FormulaFolio Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-21,440
Closed -$3.62M 655
2020
Q4
$3.62M Buy
21,440
+12,773
+147% +$1.91M 0.08% 187
2020
Q3
$1.28M Buy
8,667
+1,713
+25% +$265K 0.05% 125
2020
Q2
$1.14M Buy
6,954
+196
+3% +$30.1K 0.05% 126
2020
Q1
$937K Sell
6,758
-1,254
-16% -$172K 0.05% 126
2019
Q4
$1.05M Buy
8,012
+4,644
+138% +$538K 0.04% 168
2019
Q3
$377K Buy
3,368
+240
+8% +$26.7K 0.01% 250
2019
Q2
$347K Buy
3,128
+388
+14% +$45.7K 0.01% 249
2019
Q1
$356K Sell
2,740
-252
-8% -$30.6K 0.02% 244
2018
Q4
$321K Hold
2,992
0.01% 257
2018
Q3
$321K Buy
2,992
+313
+12% +$31.3K 0.01% 257
2018
Q2
$229K Buy
+2,679
New +$220K 0.01% 278

Other funds holding LLY

FormulaFolio Investments's LLY Position: Q1 2021 in Review

FormulaFolio Investments sold out of Eli Lilly (LLY) in Q1 2021, closing a stake of 21,440 shares — an estimated $3.62M sold.

FormulaFolio Investments first reported a position in LLY in Q2 2018 and held it in 11 quarters. The position peaked at $3.62M in Q4 2020. 1,948 funds tracked by Wall St. Rank hold LLY as of Q1 2021.

  • FormulaFolio Investments reported no remaining Eli Lilly position as of Q1 2021 after selling out during the quarter.
  • FormulaFolio Investments sold 21,440 Eli Lilly shares in Q1 2021, an estimated $3.62M.
  • FormulaFolio Investments first reported a position in Eli Lilly in Q2 2018 and held it in 11 quarters.
  • FormulaFolio Investments's Eli Lilly position peaked at $3.62M in Q4 2020.
  • 1,948 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.

Based on FormulaFolio Investments's 13F filing for Q1 2021, filed 28 May 2021.